UNCY $0.70 another hot biotech nearing final results for their kidney disease treatment ..market cap only 24 million this one could run back to $2+ in the coming weeks ...
https://finance.yahoo.com/news/unicycive-therapeutics-announces-enrollment-first-120300532.html “OLC’s novel characteristics have the potential to make it the best-in-class phosphate binder in the billion-dollar hyperphosphatemia market. Data from this pivotal trial is the last major component to complete our data package to file a New Drug Application (NDA) and will be informative for physicians as they consider a new potential therapy for their patients. We expect to report data from the trial in the second quarter of 2024 and file the NDA shortly thereafter.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.